Serum phenytoin concentration and clinical response in patients with epilepsy.
Authors:
- Dj GannawayDGDj Gannaway
- Ge MawerGMGe Mawer
Open Access
- 1 December 1981
- journal article
- Published by Wiley
- Vol. 12 (6) , 833-839
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- TRANSFER FROM MULTIPLE TO SINGLE ANTIEPILEPTIC DRUG THERAPYThe Lancet, 1981
- Statistical Analysis of Pharmacokinetic Parameters in Epileptic Patients Chronically Treated with Anti-Epileptic Drugs1975
- Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma LevelsArchives of Neurology, 1974
- Serum Concentrations of Free Diphenylhydantoin and their Relationship To Clinical IntoxicationEpilepsia, 1973
- Plasma protein binding of diphenylhydantoin in patients with epilepsy; Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluidClinical Pharmacology & Therapeutics, 1972
- The metabolism of diphenylhydantoin (Dilantin®) following once‐daily administrationNeurology, 1972
- The distribution of plasma phenytoin levels in epileptic patientsJournal of Neurology, Neurosurgery & Psychiatry, 1970
- Diphenylhydantoin Metabolism, Blood Levels, and ToxicityArchives of Neurology, 1964
- Simple Measures of Handwriting as Indices of Drug EffectsPerceptual and Motor Skills, 1964
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960